A Heart's Journey: The Promise of Machine Preservation


The success of a heart transplant hinges on the quality of the donor organ. For decades, the standard practice has been to cool the donor heart in an ice-filled container, a method known as static cold storage (SCS). While effective, this approach has a major limitation: a ticking clock. The heart can only be safely preserved for a limited time, which restricts the distance it can be transported and the time available for the transplant surgery.

Enter machine preservation, a revolutionary technology that is changing the game. Specifically, Hypothermic Oxygenated Machine Preservation (HOPE) is emerging as a powerful new method. Instead of being stored in a passive state, the heart is connected to a portable machine that continuously perfuses it with a cold, oxygenated, and nutrient-rich solution.



Heart Transplanntation Device


How Machine Preservation Transforms Heart Transplants

Extending the Lifeline: Unlike traditional cold storage, which simply slows down the heart's metabolism, machine preservation keeps the organ "alive" and actively perfused. This dynamic process flushes out waste products that build up during the preservation period and keeps the heart's cells healthy. This significantly extends the safe preservation time, allowing for longer transport distances and more time for complex surgeries.

Expanding the Donor Pool: This technology allows transplant surgeons to use hearts that might have been considered unsuitable for transplantation under the old method, such as those from donors with certain medical conditions or from donation after circulatory death (DCD). By "reconditioning" these organs on the machine, they can be assessed for viability and potentially repaired before transplantation, ultimately expanding the number of available hearts.

A "Living" Assessment: One of the most significant advantages of machine preservation is the ability to monitor the heart's function in real-time before it is even implanted. The perfusion machine provides data on blood flow, pressure, and metabolism, giving surgeons a precise understanding of the organ's health and increasing the chances of a successful transplant.

Machine preservation is a paradigm shift in organ transplantation, moving from a passive "storage" model to an active "preservation and assessment" model. This technology is paving the way for more successful transplants and a larger, healthier donor pool, offering new hope to patients with end-stage heart failure.

To know more visit: https://www.cardiology.scientexconference.com/sessions/Cardiac-Devices-Diagnosis

Comments

Post a Comment

Popular posts from this blog

Image
  Ventricular Assist Device – Miniature The treatment of individuals with severe heart failure has been transformed by the development of a ventricular assist device (VAD). When a donor heart cannot be identified, the VAD, which was initially designed as a bridge to transplantation , has been proved to extend life and improve quality of life. Older models needed patients to ambulate with hefty , huge external batteries and control devices and required the implantation of a big pump. Yet in the upcoming years, a number of ground-breaking advancements in device size , battery life, and even wireless charging technologies may render these devices physically undetectable and possibly reduce patient vulnerability to infections. The rates of haemolysis, thrombosis, and secondary aortic valve insufficiency have also been constrained by numerous mechanical improvements and newer operating paradigms. Cardiac Decellularization and Engineered Heart Tissue Promising new direction...
Read more
Image
Myocardial infarction events involving morality, incredibly high temperatures, and minute particles.  Myocardial infarction (MI) morbidity has been connected to extreme temperature events (ETEs), such as heat wave and cold spell, but their effects on MI mortality are less well understood. Although ambient fine particulate matter (PM2.5) and severe temperatures may work in concert to increase cardiovascular mortality , it is still unclear whether or how ETEs and PM2.5 interact to cause MI deaths.METHODS: To examine the relationship between exposure to ETEs and PM2.5 and MI mortality and assess their interacting effects, a time-stratified case-crossover study of 202 678 MI deaths in Jiangsu province, China, from 2015 to 2020 was conducted. Twelve ETE definitions were created using a variety of temperature thresholds and durations based on the perceived ambient temperature. In order to estimate daily ETEs and PM2.5exposures , values were taken from validated grid datasets at reside...
Read more

New Drug Nearly Eradicates “Stealth” Cholesterol (Lp(a)) – A Game‑Changer in Heart Disease Prevention

Image
A recent clinical trial reported in the New England Journal of Medicine and showcased at the American College of Cardiology revealed that lepodisiran—an experimental RNA-targeting drug—can reduce lipoprotein(a) [Lp(a)] by nearly 100% after a single dose, with sustained effects over a year 🔍 What You Need to Know Lp(a) is a genetically determined, stealth cholesterol that significantly raises the risk of heart attacks and strokes yet is not addressed by diet or standard statins. The Phase 2 trial, involving 320 participants across 10 countries, showed almost total Lp(a) suppression at 6 months, maintained at 1 year. Reported side effects were mild, primarily limited to injection-site reactions. No serious safety issues were found.                      🌍 Why This Matters This breakthrough could pave the way for targeted Lp(a) therapies—potentially reducing cardiovascular risk in over 1.4 billion people globally with elevated levels....
Read more